Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 6

A thyrotoxicosis outbreak due to dietary pills in Paris

Authors Ioos V, Das V, Maury E, Baudel J-L, Guéchot J, Guidet B, Offenstadt G

Published 5 December 2008 Volume 2008:4(6) Pages 1375—1379


Review by Single-blind

Peer reviewer comments 5

Vincent Ioos1, Vincent Das1, Eric Maury1,2, Jean-Luc Baudel1, Jérôme Guéchot3, Bertrand Guidet1,2, Georges Offenstadt1,2

1Réanimation Médicale; 2Université Pierre et Marie Curie-Paris 6, INSERM, UMR-S 707; 3Unité d’Hormonologie, APHP, Hôpital Saint Antoine, F-75012, Paris, France

Abstract: Three women were consecutively admitted to our medical intensive care unit for thyrotoxicosis after the ingestion of dietary pills accidentally containing high levels of thyroxin. These cases were observed during an outbreak in the Paris area. Despite similar blood levels of thyroid hormones, their clinical presentation and outcome were very different. One patient developed febrile confusion and died from malignant hyperthermia. The second one had progressive confusion requiring mechanical plasma exchange therapy and had a favorable outcome. The third one had very moderate symptoms. These exceptional observations raise several issues concerning diagnosis, physiopathology and treatment of thyrotoxicosis factitia.

Keywords: thyrotoxicosis, dietary pills, thyroxin

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other article by this author:

Does nonadherence to local recommendations for empirical antibiotic therapy on admission to the intensive care unit have an impact on in-hospital mortality?

Jean-Luc Baudel, Jacques Tankovic, Fabrice Carrat, Cécile Vigneau, et al.

Therapeutics and Clinical Risk Management 2009, 5:491-498

Published Date: 9 July 2009

Readers of this article also read:

Whole-body vibration improves functional capacity and quality of life in patients with severe chronic obstructive pulmonary disease (COPD): a pilot study

Braz Júnior DS, Dornelas de Andrade A, Teixeira AS, Cavalcanti CA, Morais AB, Marinho PE

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:125-132

Published Date: 12 January 2015

The physiology of cardiovascular disease and innovative liposomal platforms for therapy

Ruiz-Esparza GU, Flores-Arredondo JH, Segura-Ibarra V, Torre-Amione G, Ferrari M, Blanco E, Serda RE

International Journal of Nanomedicine 2013, 8:629-640

Published Date: 9 February 2013

Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?

Nicola G Ghazi, Brian P Conway, James S Tiedeman, Steven J Yoon

Clinical Ophthalmology 2008, 2:773-780

Published Date: 5 December 2008

Tiotropium and exercise training in COPD patients: Effects on dyspnea and exercise tolerance

Nicolino Ambrosino, Katia Foglio, Gianni Balzano, Pier Luigi Paggiaro, Patrizia Lessi, Steven Kesten

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:771-780

Published Date: 5 December 2008

Predictors of adherence among community users of a cognitive behavior therapy website

Philip J Batterham, Alison L Neil, Kylie Bennett, Kathleen M Griffiths, Helen Christensen

Patient Preference and Adherence 2008, 2:97-105

Published Date: 19 March 2008

Patterning of polymer nanofiber meshes by electrospinning for biomedical applications

Nuno M Neves, Rui Campos, Adriano Pedro, José Cunha, Francisco Macedo, Rui L Reis

International Journal of Nanomedicine 2007, 2:433-448

Published Date: 15 October 2007

Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results

Marco Metra, Savina Nodari, Tania Bordonali, Patrizia Milani, Carlo Lombardi, et al

Therapeutics and Clinical Risk Management 2007, 3:569-578

Published Date: 15 September 2007